CH505 TF chTrimer
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CH505 TF chTrimer, covering 2025-10-07 to 2025-10-07. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of Safety and Immunogenicity of Ad26.Mos4.HIV and CH505 TF chTrimer Combination in Healthy Adults [Phase 1]